Sort
51,570 grants matching “autoimmune disease”
Chronic kidney disease of unknown etiology: applying a multidisciplinary approach to investigate the world's most common tubulointerstitial kidney disease
$543,755Shuchi Anand · Stanford University · R01 · FY2022 · DK
Defining and Controlling Protein-RNA interactions in editing and interference pathways
$543,734Peter A. Beal · University Of California At Davis · R35 · FY2023 · GM
miR-21 regulation of autoreactive B cell and lupus nephritis development
$543,727Ziaur Rahman · Thomas Jefferson University · R01 · FY2023 · AI
Role of Cell Adhesion and the Cytoskeleton in Epidermal Integrity
$543,722Terry H Lechler · Duke University · R01 · FY2017 · AR
Targeted depletion of programmed death-1 positive cells, a method that not only stops autoimmune attack but also preserves adaptive immunity
$543,680Mingnan Chen · University Of Utah · R01 · FY2020 · AI
B-lymphocyte Targeting Therapies for Autoimmune Diabetes
$543,679David V. Serreze · Jackson Laboratory · R01 · FY2023 · DK
B-lymphocyte Targeting Therapies for Autoimmune Diabetes
$543,679David V. Serreze · Jackson Laboratory · R01 · FY2025 · DK
Mechanisms of Impaired HIV-associated B cell and Pneumococcal Vaccine responses
$543,677Edward N Janoff · University Of Colorado Denver · R01 · FY2014 · AI
Finding the optimal balance of immunotherapy efficacy and toxicity.
$543,590David Eric Gerber · Ut Southwestern Medical Center · U01 · FY2024 · AI
COVID Immunophenotyping Study
$543,574Jane Hoyt Buckner · Benaroya Research Inst At Virginia Mason · R01 · FY2020 · AI
Mechanism of microbiota-mediated potentiation of checkpoint blockade efficacy in lung cancer
$543,560Dan R Littman · New York University School Of Medicine · R01 · FY2024 · CA
Chronic kidney disease of unknown etiology: applying a multidisciplinary approach to investigate the world's most common tubulointerstitial kidney disease
$543,539Shuchi Anand · Stanford University · R01 · FY2023 · DK
Immunogenomics and Systems Biology Core
$543,378Johann Eli Gudjonsson · University Of Michigan At Ann Arbor · UC2 · FY2023 · AR
Investigating the basis of MAIT cell antigen potency
$543,227James McCluskey · University Of Melbourne · R01 · FY2020 · AI
REGULATION OF ATROPHY-INDUCED PROGENITOR CELLS IN THE GASTRIC CORPUS
$543,005Jason C Mills · Baylor College Of Medicine · R01 · FY2025 · DK
Molecular and Cellular Immunology
$542,995Anthony L. Defranco · University Of California, San Francisco · T32 · FY2011 · AI
Interrogating the ubiquitin pathway to understand and treat cytokine-induced beta-cell death in type 1 diabetes
$542,971Amit Choudhary · Broad Institute, Inc. · R01 · FY2023 · DK
Regulatory B Cell in the Amelioration of Immune-Mediated Periodontal Disease
$542,946Xiaozhe Han · Nova Southeastern University · R01 · FY2024 · DE
iPLA2beta-mediated alternative splicing and beta-cell death in type 1 diabetes
$542,840Charles E Chalfant · University Of Virginia · R01 · FY2022 · DK
Early Pathogenic Steps in Xenobiotic-Induced Autoimmunity
$542,761Kenneth Michael Pollard · Scripps Research Institute, The · R01 · FY2025 · ES
Molecular basis of receptor-ligand recognition in the Immunological Synapse
$542,750Andras Fiser · Albert Einstein College Of Medicine · R01 · FY2019 · GM
Molecular basis of receptor-ligand recognition in the Immunological Synapse
$542,750Andras Fiser · Albert Einstein College Of Medicine, Inc · R01 · FY2017 · GM
Molecular basis of receptor-ligand recognition in the Immunological Synapse
$542,750Andras Fiser · Albert Einstein College Of Medicine, Inc · R01 · FY2016 · GM
Regulation of Human PD-1 Gene Expression
$542,699Jeremy M. Boss · Emory University · R01 · FY2021 · AI
EPIDEMIOLOGY OF PRIMARY BILIARY CIRRHOSIS
$542,676University Of California Davis · R01 · FY2001 · DK